SCHEMBL3890955

SCHEMBL3890955

[CH2]C(=O)Nc1cc(Cl)cc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
RAB9A P51151 1/20 0.53
P2RY1 P47900 1/20 0.50
POLB P06746 1/20 0.50
ACP1 P24666 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
P2RX1 P51575 1/20 0.47
P2RX4 Q99571 1/20 0.47
P2RX7 Q99572 1/20 0.47
TMPRSS4 Q9NRS4 1/20 0.47
FABP4 P15090 1/20 0.47
IDO1 P14902 1/20 0.47
GRM4 Q14833 2/20 0.46
FADS1 O60427 1/20 0.46
EGFR P00533 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15786287 0.80 MEN1 (0.76) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL9835677 0.78 MEN1 (0.55) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2090730 0.78 MEN1 (0.55) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL711831 0.78 MEN1 (0.61) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL351911 0.76 MEN1 (0.53) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL1002285 0.76 NPC1 (0.61) MEN1KMT2AMAPTRAB9APOLB
SCHEMBL2728856 0.76 LMNA (0.58) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2891974 0.76 NPC1 (0.61) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL2095413 0.76 MEN1 (0.49) MEN1KMT2AMAPTNPSR1RAB9A
SCHEMBL6128910 0.74 MEN1 (0.57) MEN1KMT2AMAPTNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9850203-B2 Autotaxin inhibitor compounds PHARMAKEA, INC. (US) 2017-12-26 US disclosed
US-20160214935-A1 AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2016-07-28 US disclosed
US-7605134-B2 Pesticides MERIAL LIMITED (US) 2009-10-20 US disclosed
EP-1421094-B1 4\"-DEOXY-4\"-(S)-AMINO AVERMECTIN DERIVATIVES MERIAL LTD (GB) 2008-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214935-A1 AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885MAPT 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.